Timber Pharmaceuticals Inc. (TMBR:NYSEMKT) soared at $2.65, representing a gain of 37.3%. On Fri, Feb 24, 2023, TMBR:NYSEMKT touched a New 2-Week High of $2.65. The stock got featured on our News Catalysts scanner on Fri, Feb 24, 2023 at 08:53 AM in the 'BIOTECH' category. From Fri, Feb 10, 2023, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Wed, Sep 14, 2022 at $8.75 with a volume of 1M+.
About Timber Pharmaceuticals Inc. (TMBR:NYSEMKT)
Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases.
Top 10 Gainers:
- Bridger Aerospace Group Holdings Inc. (BAER:NASDAQ), 78.73%
- CYREN Ltd. (CYRN:NASDAQ), 61.9%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 49.43%
- Cingulate Inc. (CING:NASDAQ), 43.12%
- Decarbonization Plus Acquisition Corporation IV (DCRD:NASDAQ), 40.52%
- Timber Pharmaceuticals Inc. (TMBR:NYSEMKT), 37.31%
- Avita Medical Limited (RCEL:NASDAQ), 36.53%
- OncoSec Medical Incorporated (ONCS:NASDAQ), 28.71%
- Danimer Scientific Inc. (DNMR:NYSE), 27.5%
- Nuburu Inc. (BURU:NYSEMKT), 26.52%